Innoviva - 9 Year Dividend History | INVA

Historical dividend payout and yield for Innoviva (INVA) since 2016. The current TTM dividend payout for Innoviva (INVA) as of May 27, 2025 is $0.00. The current dividend yield for Innoviva as of May 27, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.191B $0.359B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $676.408B 51.87
Johnson & Johnson (JNJ) United States $367.985B 15.22
AbbVie (ABBV) United States $323.711B 17.84
Novo Nordisk (NVO) Denmark $302.235B 19.93
Roche Holding AG (RHHBY) Switzerland $253.013B 0.00
Novartis AG (NVS) Switzerland $238.176B 13.60
Merck (MRK) United States $194.806B 9.96
Pfizer (PFE) United States $132.583B 7.26
Sanofi (SNY) France $127.479B 12.56
Bayer (BAYRY) Germany $27.508B 5.60